| 1 |
35500745 | PRMT5 determines the pattern of polyploidization and prevents liver from cirrhosis and carcinogenesis. | 2022 Apr 30 |
1 |
| 2 |
33682127 | Gelation and microstructural properties of fish myofibrillar protein gels with the incorporation of l-lysine and l-arginine at low ionic strength. | 2021 Oct |
2 |
| 3 |
32821748 | Evaluation of TP53 Codon 72, P21 Codon 31, and MDM2 SNP309 Polymorphisms in Iranian Patients with Acute Lymphocytic Leukemia. | 2020 Apr |
1 |
| 4 |
29568320 | Protein arginine methylation: an emerging regulator of the cell cycle. | 2018 |
1 |
| 5 |
28367100 | PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients. | 2017 |
3 |
| 6 |
25232917 | Clinical impact of SNP of P53 genes pathway on the adult AML patients. | 2015 Jul |
3 |
| 7 |
26405550 | Association of p53 and p21 polymorphisms with prostate cancer. | 2015 Sep |
4 |
| 8 |
26420673 | Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. | 2015 Sep 30 |
1 |
| 9 |
24384472 | The impact of R213 mutation on p53-mediated p21 activity. | 2014 Apr |
1 |
| 10 |
23071787 | The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk. | 2012 |
2 |
| 11 |
23167335 | MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia. | 2012 |
1 |
| 12 |
21454715 | Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53. | 2011 May 13 |
1 |
| 13 |
21790217 | An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism. | 2011 |
1 |
| 14 |
20022955 | Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17. | 2010 Mar 5 |
1 |
| 15 |
20524403 | P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women. | 2010 |
1 |
| 16 |
20732856 | Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women. | 2010 Sep |
4 |
| 17 |
18640142 | Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma. | 2008 Oct 15 |
2 |
| 18 |
17477906 | Cytoplasmic localization and ubiquitination of p21(Cip1) by reactive oxygen species. | 2007 Jun 22 |
1 |
| 19 |
16697770 | Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease. | 2006 May |
5 |
| 20 |
15807891 | A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians. | 2005 Apr 4 |
2 |
| 21 |
16054204 | Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. | 2005 Oct |
3 |
| 22 |
15099969 | p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. | 2004 May |
2 |
| 23 |
15530866 | MIBG, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents differentiation of L6 skeletal myoblasts by inhibiting expression of myogenin and p21(cip1). | 2004 Dec 10 |
1 |
| 24 |
15598783 | p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. | 2004 Dec |
2 |
| 25 |
14607331 | Association between p21 codon 31 polymorphism and esophageal cancer risk in a Taiwanese population. | 2003 Nov 25 |
2 |
| 26 |
12474524 | p21 gene codon 31 polymorphism is associated with bladder cancer. | 2002 Mar-Apr |
1 |
| 27 |
11436200 | p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis. | 2001 |
3 |
| 28 |
10735543 | Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product. | 2000 Feb |
1 |
| 29 |
10837517 | Detection of point mutations in promoter and coding sequence of p21 gene in a variety of human malignancies. | 2000 Jun |
1 |
| 30 |
10866325 | Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. | 2000 Jun 15 |
1 |
| 31 |
11188692 | Structural changes induced in p21Ras upon GAP-334 complexation as probed by ESEEM spectroscopy and molecular-dynamics simulation. | 2000 Dec 15 |
1 |
| 32 |
7971997 | Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein. | 1994 Nov 8 |
1 |
| 33 |
7691613 | Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells. | 1993 Oct |
2 |
| 34 |
8246952 | Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction. | 1993 Dec |
1 |
| 35 |
1639630 | T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides. | 1992 Apr |
1 |
| 36 |
2052624 | GTPase domains of ras p21 oncogene protein and elongation factor Tu: analysis of three-dimensional structures, sequence families, and functional sites. | 1991 Jun 15 |
4 |
| 37 |
2164357 | Electron paramagnetic resonance measurements of the hydration of Mn(II) in ternary complexes with GDP and ras p21 proteins. | 1990 Aug 1 |
1 |
| 38 |
2471068 | H-ras mutants lacking the epitope for the neutralizing monoclonal antibody Y13-259 show decreased biological activity and are deficient in GTPase-activating protein interaction. | 1989 Apr |
1 |
| 39 |
2669815 | Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein. | 1989 Feb |
1 |
| 40 |
3035212 | Biologic and molecular characterization of two newly isolated ras-containing murine leukemia viruses. | 1987 Jul |
1 |
| 41 |
6311615 | A synthetic peptide containing the autophosphorylation site of the transforming protein of Harvey sarcoma virus is phosphorylated by the EGF-stimulated tyrosine kinase. | 1983 Mar 21 |
2 |